| Dr Maria R Constien, MD | |
|
Mt. Scott Medical Office, 9800 Se Sunnyside Rd, Clackamas, OR 97015-9750 | |
| (503) 653-6440 | |
| Not Available |
| Full Name | Dr Maria R Constien |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | Mt. Scott Medical Office, Clackamas, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154416535 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | OR MD16595 (Oregon) | Primary |
| Entity Name | Kaiser Foundation Health Plan Of The Northwest |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184786527 PECOS PAC ID: 5799688230 Enrollment ID: O20040130000799 |
News Archive
Oncologists at the University and University Hospital in Tübingen have discovered a new protein variant that plays an important role in the development and therapy response of cancer.
The National Association For Continence (NAFC) has released a new consumer educational resource, focusing on catheterization procedures and care in the United States. The Urinary Catheterization of Men and Women pamphlet is the newest addition to NAFC's library of educational materials available to consumers seeking knowledge of management and treatment options for medical problems related to incontinence. It is also helpful as an educational supplement to nurses giving instructions to patients regarding their self-care.
With a price tag of about $3 billion, the agreement ends a decade-long dispute between an estimated 2,200 hospitals and the Centers for Medicare & Medicaid Services over the calculation of pay rate cuts and offsets for rural hospitals.
A recently published study in the American Journal of Rhinology and Allergy demonstrates Balloon Sinuplasty™ technology to be safe when used by physicians in pediatric patients. Known as the INTACT study, this is a prospective, non-randomized, multicenter study and was sponsored by Acclarent, Inc.
The tyrosine kinase inhibitor afatinib significantly improved progression-free survival compared to methotrexate in patients with recurrent or metastatic squamous cell carcinoma of the head and neck after failure of platinum-based chemotherapy, the results of a phase III trial show.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Maria R Constien, MD Po Box 927, Gresham, OR 97030 Ph: (503) 667-4700 | Dr Maria R Constien, MD Mt. Scott Medical Office, 9800 Se Sunnyside Rd, Clackamas, OR 97015-9750 Ph: (503) 653-6440 |
News Archive
Oncologists at the University and University Hospital in Tübingen have discovered a new protein variant that plays an important role in the development and therapy response of cancer.
The National Association For Continence (NAFC) has released a new consumer educational resource, focusing on catheterization procedures and care in the United States. The Urinary Catheterization of Men and Women pamphlet is the newest addition to NAFC's library of educational materials available to consumers seeking knowledge of management and treatment options for medical problems related to incontinence. It is also helpful as an educational supplement to nurses giving instructions to patients regarding their self-care.
With a price tag of about $3 billion, the agreement ends a decade-long dispute between an estimated 2,200 hospitals and the Centers for Medicare & Medicaid Services over the calculation of pay rate cuts and offsets for rural hospitals.
A recently published study in the American Journal of Rhinology and Allergy demonstrates Balloon Sinuplasty™ technology to be safe when used by physicians in pediatric patients. Known as the INTACT study, this is a prospective, non-randomized, multicenter study and was sponsored by Acclarent, Inc.
The tyrosine kinase inhibitor afatinib significantly improved progression-free survival compared to methotrexate in patients with recurrent or metastatic squamous cell carcinoma of the head and neck after failure of platinum-based chemotherapy, the results of a phase III trial show.
› Verified 7 days ago
Pooja Banginwar, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8645 Se Sunnybrook Blvd Ste 200, Clackamas, OR 97015 Phone: 503-659-1694 Fax: 503-659-8984 | |
Jay Joo, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 9800 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-813-2000 | |
Dr. Bonnie Jean Aust, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 10180 Se Sunnyside Rd, Kaiser Sunnyside Medical Office, Clackamas, OR 97015 Phone: 503-652-2880 | |
Dr. Patricia Theresa Campbell, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 9800 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-571-3418 | |
Mary Kathryn Brown, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 9290 Se Sunnybrook Blvd, Suite 200, Clackamas, OR 97015 Phone: 503-659-1694 Fax: 503-659-8984 | |
Dr. Tracy Jeanne Peck, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 9000 Se Sunnyside Rd, Clackamas, OR 97015 Phone: 503-813-2000 Fax: 503-571-3418 | |
Nancy Tran Chen, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 8645 Se Sunnybrook Blvd Ste 200, Clackamas, OR 97015 Phone: 503-659-1694 Fax: 503-659-8984 |